年轻成人糖尿病技术在儿科的使用与成人实践相比
Sean DeLacey1, Saketh Rompicherla2, Jody Grundman3
1Division of Endocrinology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
概括
患有1型糖尿病 (T1D) 的年轻人在过渡到成人护理期间面临挑战. 与儿科设置相比,在成人护理环境中的患者表现出较差的糖尿病控制和较少的技术使用.
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病管理 糖尿病管理
- 公共卫生 公共卫生
背景情况:
- 在新兴成年期1型糖尿病 (T1D) 管理提出了独特的挑战.
- 从儿科到成人医疗保健系统的过渡可能会影响疾病的结果.
- 高血红蛋白A1C (HbA1C) 水平在患有T1D的年轻人中很常见.
研究的目的:
- 为了比较儿童和成人医疗机构中T1D的年轻成年人的疾病结果和护理实践.
- 在护理环境之间识别糖尿病控制,并发症和技术使用的差异.
主要方法:
- 使用T1D交换数据 (2022-2023) 对18-23岁T1D患者的回顾性审查.
- 根据护理地点对患者进行分类:儿科 (n=8538) 与成人 (n=839) 机构.
- 后勤回归分析以比较最佳/差的血糖控制 (HbA1C水平),急性并发症和技术采用.
主要成果:
- 在成人机构的年轻人比较年长,更有可能拥有无证保险.
- 尽管在两组中都使用了高科技,但在成人环境中的人患糖尿病控制较差 (OR 1.23).
- 成人护理环境与较少使用连续血糖监测器 (OR 0.64) 和胰岛素 (OR 0.62) 相关.
结论:
- 与儿童中心相比,在成人机构接受护理的T1D年轻人表现出更差的血糖控制和减少糖尿病技术的采用.
- 局限性包括不平等的区域代表和较小的成人中心人口.
- 进一步的研究至关重要,以了解和解决在成人实践中使用YA技术的障碍.
相关概念视频
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Insulin: Dosing Regimen and Adverse Effects
689
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
689
Drug Dosing: Infants and Children
256
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
256


